EP3412260A1 — Drug eluting ocular implant
Assigned to Dose Medical Corp · Expires 2018-12-12 · 7y expired
What this patent protects
A drug delivery ocular implant (53), comprising an outer shell (54) shaped to define an interior space, one closed distal end, and one open proximal end; a drug (62) contained within the interior space (58); a cap (54a) dimensioned to fit within or over the one open end and havin…
USPTO Abstract
A drug delivery ocular implant (53), comprising an outer shell (54) shaped to define an interior space, one closed distal end, and one open proximal end; a drug (62) contained within the interior space (58); a cap (54a) dimensioned to fit within or over the one open end and having at least one region (56) of drug release; a permeable or semi-permeable material covering the at least one region of drug release, the permeable or semi-permeable material being permeable or semi-permeable to the drug; and a retention protrusion (359) on the closed distal end.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.